Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HDAC inhibitors overcome first hurdle.

× No keyword cloud information.

30 in total

1. Largazole and analogues with modified metal-binding motifs targeting histone deacetylases: synthesis and biological evaluation.

Authors: Pravin Bhansali; Christin L Hanigan; Robert A Casero; L M Viranga Tillekeratne
Journal: J Med Chem Date: 2011-10-10 Impact factor: 7.446

2. Analysis of Human Nuclear Protein Complexes by Quantitative Mass Spectrometry Profiling.

Authors: Katelyn E Connelly; Victoria Hedrick; Tiago Jose Paschoal Sobreira; Emily C Dykhuizen; Uma K Aryal
Journal: Proteomics Date: 2018-05-04 Impact factor: 3.984

Review 3. Isoform-selective histone deacetylase inhibitors.

Authors: Anton V Bieliauskas; Mary Kay H Pflum
Journal: Chem Soc Rev Date: 2008-05-08 Impact factor: 54.564

4. The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.

Authors: Sun Ea Choi; Sujith V W Weerasinghe; Mary Kay H Pflum
Journal: Bioorg Med Chem Lett Date: 2011-08-12 Impact factor: 2.823

Review 5. Intelligent design: combination therapy with oncolytic viruses.

Authors: Kathryn Ottolino-Perry; Jean-Simon Diallo; Brian D Lichty; John C Bell; J Andrea McCart
Journal: Mol Ther Date: 2009-12-22 Impact factor: 11.454

Review 6. Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors: Panagis Filippakopoulos; Stefan Knapp
Journal: Nat Rev Drug Discov Date: 2014-04-22 Impact factor: 84.694

Review 7. Epigenetic regulation in RCC: opportunities for therapeutic intervention?

Authors: James Larkin; Xin Yi Goh; Marcus Vetter; Lisa Pickering; Charles Swanton
Journal: Nat Rev Urol Date: 2012-01-17 Impact factor: 14.432

Review 8. Epigenomics and breast cancer.

Authors: Pang-Kuo Lo; Saraswati Sukumar
Journal: Pharmacogenomics Date: 2008-12 Impact factor: 2.533

9. Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines.

Authors: Yasmine Haddad; Woonyoung Choi; David J McConkey
Journal: Clin Cancer Res Date: 2009-01-15 Impact factor: 12.531

10. Alternative Modes of Binding of Recombinant Human Histone Deacetylase 8 to Colloidal Gold Nanoparticles.

Authors: Nitesh Sule; Raushan Singh; D K Srivastava
Journal: J Biomed Nanotechnol Date: 2008-12-01 Impact factor: 4.099